statistiche ricercatore

ANGELI, FABIO

Distribuzione geografica

Continente	#
NA - Nord America	13.863
EU - Europa	9.898
AS - Asia	930
SA - Sud America	7
AF - Africa	5
Continente sconosciuto - Info sul continente non disponibili	4
OC - Oceania	2
Totale	24.709

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	13.857
IT - Italia	6.167
UA - Ucraina	1.667
IE - Irlanda	748
VN - Vietnam	641
DE - Germania	532
SE - Svezia	370
GB - Regno Unito	318
CN - Cina	188
TR - Turchia	55
FR - Francia	26
FI - Finlandia	24
IN - India	21
AT - Austria	11
CZ - Repubblica Ceca	8
PK - Pakistan	7
BR - Brasile	5
CA - Canada	5
NL - Olanda	5
RO - Romania	5
EU - Europa	4
ES - Italia	3
JP - Giappone	3
KE - Kenya	3
AU - Australia	2
CH - Svizzera	2
GR - Grecia	2
MY - Malesia	2
PH - Filippine	2
RS - Serbia	2
SG - Singapore	2
AM - Armenia	1
BE - Belgio	1
BG - Bulgaria	1
CL - Cile	1
CO - Colombia	1
EE - Estonia	1
EG - Egitto	1
HK - Hong Kong	1
HR - Croazia	1
IL - Israele	1
IQ - Iraq	1
KR - Corea	1
KZ - Kazakistan	1
LK - Sri Lanka	1
LU - Lussemburgo	1
MX - Messico	1
OM - Oman	1
RU - Federazione Russa	1
SA - Arabia Saudita	1
SI - Slovenia	1
SK - Slovacchia (Repubblica Slovacca)	1
ZA - Sudafrica	1
Totale	24.709

Salva come PNG Salva come JPEG

Città	#
Milan	4.664
Fairfield	2.751
Ashburn	1.798
Woodbridge	1.298
Seattle	1.098
Wilmington	1.035
Houston	1.023
Cambridge	937
Jacksonville	885
Dublin	734
Princeton	650
Rome	447
Ann Arbor	404
Chandler	397
Dong Ket	330
Nyköping	234
San Diego	221
Washington	200
Ogden	136
Beijing	91
London	85
New York	78
Kocaeli	53
Boardman	26
Los Angeles	23
Norwalk	23
Prescot	23
Helsinki	19
Kilburn	19
Redmond	17
Treviglio	17
Kunming	14
Chiswick	13
Como	13
Redwood City	12
Acton	11
Hefei	11
Vienna	11
Hounslow	10
Nanjing	10
Southwark	10
Wandsworth	10
Chennai	9
Varese	9
Brno	8
Olgiate Comasco	8
Shanghai	7
Bergamo	6
Jinan	6
Menlo Park	6
New Bedfont	6
Pune	6
Chicago	5
Guangzhou	5
Magnago	5
Nanchang	5
San Genesio Ed Uniti	5
Zhengzhou	5
Bassano del Grappa	4
Hebei	4
Lappeenranta	4
Leawood	4
Paris	4
San Francisco	4
Shenyang	4
Stockholm	4
Toronto	4
Wuhan	4
Xian	4
Alleppey	3
Amsterdam	3
Esslingen am Neckar	3
Ferentino	3
Frankfurt am Main	3
Fuzhou	3
Greenwich	3
Lesmo	3
Phoenix	3
São Paulo	3
Tokyo	3
Turin	3
Atlanta	2
Belgrade	2
Berlin	2
Buffalo	2
Catania	2
Chongqing	2
Cologne	2
Edinburgh	2
Florence	2
Islington	2
Istanbul	2
Kuala Lumpur	2
Manila	2
Osimo	2
San Jose	2
San Polo	2
Shaoxing	2
Singapore	2
Acqui Terme	1
Totale	20.059

Salva come PNG Salva come JPEG

Nome	#
Response to Is Vascular Morning Blood Pressure Surge in the Elderly Resistant to Antihypertensives and More Risky?	200
How can we use the results of ambulatory blood pressure monitoring in clinical practice?	179
Optimal Therapy in Hypertensive Subjects with Diabetes Mellitus	170
Circadian rhythm of pulse pressure in hypertension: Prognostic implications	165
Association between periodontal disease and left ventricle mass in essential hypertension	162
Simplifying the ECG Diagnosis of Left Ventricular Hypertrophy	154
Good news for beta-blockers in perioperative medicine	138
Exploring the optimal combination therapy in hypertensive patients with diabetes mellitus	131
Intensive Blood Pressure Lowering and Regression of Left Ventricular Hypertrophy	127
DAY-NIGHT RELATED EVENTS: NIGHTTIME BLOOD PRESSURE FALL AND MORNING BLOOD PRESSURE RISE	122
Microcirculation and left-ventricular hypertrophy	122
Angiotensin-converting enzyme inhibitors, angiotensin receptor blockers and protection from stroke	120
Sudden Cardiac Death in Hypertensive Patients	118
Above Which Blood Pressure Level Does the Risk of Atrial Fibrillation Increase?	117
Dabigatran vs. warfarin in relation to the presence of left ventricular hypertrophy in patients with atrial fibrillation-the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) study	116
Safety and efficacy of aliskiren in the treatment of hypertension: a systematic overview	113
Aggressive blood pressure reduction in patients at high vascular risk: Is it dangerous?	112
Modernization and hypertension: is the link changing?	112
Interpretation of Ambulatory Blood Pressure Profile for Risk Stratification Keep It Simple	110
Hypertension and the J-curve phenomenon: implications for tight blood pressure control	110
The clinical significance of white-coat and masked hypertension	109
Amlodipine and celecoxib for treatment of hypertension and osteoarthritis pain	109
Adverse prognostic significance of new diabetes in treated hypertensive subjects	109
At the beginning of stiffening - Endothelial dysfunction meets "pulsology"	108
PK/PD evaluation of fimasartan for the treatment of hypertension Current evidences and future perspectives	108
The optimal blood pressure target for patients with coronary artery disease	108
Aggressive Blood Pressure Lowering Is Dangerous: The J-Curve Con Side of the Argument	107
Long-term outcome in patients with non-valvular atrial fibrillation on dabigatran: a prospective cohort study	106
How important is to reduce sodium and increase potassium in patients with hypertension?	105
Ambulatory blood pressure monitoring and prognosis in the management of essential hypertension	105
Neutrophil Count for the Identification of Postmenopausal Hypertensive Women at Increased Cardiovascular Risk	105
Very early initiation of statin therapy and mortality in patients with acute coronary syndrome	104
Echocardiographic left ventricular hypertrophy in hypertension: marker for future events or mediator of events?	103
Pulse pressure affects the relationship between flow-mediated dilatation and cardiovascular risk	103
Cardiac Benefits of an Intensive Blood Pressure Control in Diabetes Mellitus	103
Ambulatory blood pressure for cardiovascular risk stratification	103
Detrimental Effects of Hyperglycemia in Acute Coronary Syndromes: from Pathophysiological Mechanisms to Therapeutic Strategies	103
Does brachial pulse pressure predict coronary events?	102
A Risk Score for Predicting 1-Year Mortality in Patients >= 75 Years of Age Presenting With Non-ST-Elevation Acute Coronary Syndrome	102
White-coat hypertension in adults	101
What to Do When Blood Pressure Is Between 130/80 and 139/89 mm Hg?	101
Impact of blood pressure variability on cardiac and cerebrovascular complications in hypertension	101
Response to Role of Yin and Yang in Diurnal Blood Pressure Variation for Cardiovascular Disease	100
Aliskiren versus ramipril in hypertension	100
Is Hydrochlorothiazide More Effective on LVH in Nonresponders to Losartan Than in Those to Atenolol?	100
Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis	100
Improved cardiovascular risk stratification by a simple ECG index in hypertension	100
Hyperglycemia in acute coronary syndromes: From mechanisms to prognostic implications	100
Angiotensin-converting enzyme inhibitors	99
Estimate of white-coat effect and arterial stiffness	99
Early Invasive Versus Selectively Invasive Strategy in Patients With Non-ST- Segment Elevation Acute Coronary Syndrome: Impact of Age	99
The emerging role of high-density lipoprotein cholesterol in hypertension trials	99
Risk of cardiovascular disease in relation to achieved office and ambulatory blood pressure control in treated hypertensive subjects	98
Electrocardiographic abnormalities of left ventricular repolarization: Prognostic implications in hypertensive post-menopausal women	98
Day-Night Dip and Early-Morning Surge in Blood Pressure in Hypertension Prognostic Implications	97
Prognostic value of serial Electrocardiographic voltage and repolarization changes in essential hypertension: The HEART survey study	97
Atrial fibrillation in hypertension - Predictors and outcome	96
Hypertension, inflammation and atrial fibrillation	96
Neutrophil Count and Ambulatory Pulse Pressure as Predictors of Cardiovascular Adverse Events in Postmenopausal Women with Hypertension	96
Day-to-day variability of electrocardiographic diagnosis of left ventricular hypertrophy in hypertensive patients. Influence of electrode placement	96
Risk of stroke in white-coat hypertension: A multinational registry	96
Atrial Fibrillation and Mortality in Patients with Acute Myocardial Infarction: A Systematic Overview and Meta-analysis	95
Left Ventricular Hypertrophy and Coronary Artery Calcifications: A Dangerous Duet?	95
Compared with whom? Addressing the prognostic value of ambulatory blood pressure categories	95
Blood pressure lowering in diabetic patients	95
Atrial activation analysis by surface P wave and multipolar esophageal recording after cardioversion of persistent atrial fibrillation	95
Additive value of standard ECG for the risk prediction of hypertensive disorders during pregnancy	95
The voltage of R wave in lead aVL improves risk stratification in hypertensive patients without ECG left ventricular hypertrophy	94
Safety and efficacy of aliskiren in the treatment of hypertension and associated clinical conditions	94
Meta-analysis of effectiveness or lack thereof of angiotensin-converting enzyme inhibitors for prevention of heart failure in patients with systemic hypertension	94
Short- and long-term incidence of stroke in white-coat hypertension	94
Finding a place for aliskiren in the wide spectrum of blood pressure lowering agents	94
New-onset diabetes, antihypertensive treatment, and outcome	94
Assessment of the optimal daily dose of valsartan in patients with hypertension, heart failure, or both	93
Natural history of hypertension subtypes	93
Clinical significance of the blood pressure changes from day to night	93
Do angiotensin II receptor blockers increase the risk of myocardial infarction?	93
Renal dysfunction, coronary revascularization and mortality among elderly patients with non ST elevation acute coronary syndrome	92
Pharmacokinetic, pharmacodynamic and clinical evaluation of aliskiren for hypertension treatment	92
Does the reduction in systolic blood pressure alone explain the regression of left ventricular hypertrophy?	92
Influence of blood pressure reduction on composite cardiovascular endpoints in clinical trials	92
Angiotensin-converting enzyme inhibitors and calcium channel blockers for coronary heart disease and stroke prevention	92
Safety and efficacy of non-vitamin K oral anticoagulants in non-valvular atrial fibrillation: a Bayesian meta-analysis approach	92
New-onset diabetes in treated hypertensive patients	92
Blood pressure reduction and renin-angiotensin system inhibition for prevention of congestive heart failure: a meta-analysis	91
Validation of the A&D UA-705 device for self-measurement of blood pressure according to the British Hypertension Society protocol	91
European and US guidelines for arterial hypertension: similarities and differences	91
The Evolution and Refinement of Traditional Risk Factors for Cardiovascular Disease	91
Adverse prognostic significance of new diabetes in treated hypertensive subjects	91
Prognostic value of lipoprotein fractions in essential hypertension	91
PROGNOSTIC VALUE OF URIC ACID IN RELATION TO DIFFERENT AMBULATORY BLOOD PRESSURE COMPONENTS IN THE ABP-INTERNATIONAL STUDY	90
Effects of barnidipine on blood pressure and left ventricular diastolic function in patients with hypertension and metabolic syndrome: A 12-week, open-label noncomparison study	90
Circadian rhythm of pulse pressure in hypertension: Prognostic implications	90
Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials	90
Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: A meta-analysis	90
Clinical usefulness of ambulatory blood pressure monitoring	90
Tight Blood Pressure Control in Diabetes: Evidence-Based Review of Treatment Targets in Patients with Diabetes	90
Angiotensin-converting enzyme inhibitors	89
Hypertension and Atrial Fibrillation Doubts and Certainties From Basic and Clinical Studies	89
Single and dual blockade of the renin-angiotensin system in high-risk patients without heart failure: Lessons from ONTARGET	89
Totale	10.462

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	105.130
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	105.130

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	5.188	0	0	0	0	0	678	1.282	1.082	820	558	195	573
2020/2021	7.218	55	1.246	354	937	206	1.072	268	640	728	401	421	890
2021/2022	2.848	271	509	61	89	82	120	183	221	193	444	309	366
2022/2023	2.028	341	75	82	146	91	513	15	234	248	169	59	55
2023/2024	7.880	1.111	1.235	1.191	1.477	1.746	771	46	61	200	39	3	0
Totale													25.162